UBS lowered the target price for Wuxi Bio (02269) to HKD16.6 from HKD17.6 and maintained the "neutral" rating.
The research house said it fine-tuned its model and trimmed 2024/25 EPS estimates by 7.3%/6.3%.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情